Your selection
Innovation / 28.07.2025
Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation.
The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) resolved on June 18, 2025, to increase the share capital using company funds by € 42,343,864 to € 63,515,796.
The capital increase was entered in the commercial register on 25 July 2025 and thus became effective. As a result, the company's share capital increased from € 21,171,932 to € 63,515,796.
The company will report on the exact details of the share split once the technical details have been finalized with the banks.
The share split aims in particular to increase the liquidity of the share and thus facilitate the tradability of Eckert & Ziegler shares.
About Eckert & Ziegler.
Eckert & Ziegler SE with more than 1.000 employees, is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Source: Press Release Eckert & Ziegler
Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation
Overview News
News Buch Berlin
Eckert & Ziegler and DC Pharma Open Commercial Medical Isotope Production Site in Jintan
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today officially opened the new medical isotope production site of its joint venture Qi Kang Medical Technology (Changzhou) Co., Ltd. (QKM) in the Jinta...
more ...Berlin honors outstanding deep-tech companies—including MyoPax
This year, for the first time, a Deep Tech Award was presented in the Bio & Health Tech category. The winner is MyoPax, a spin-off of the Max Delbrück Center and Charité.
more ...Eckert & Ziegler Receives “Best Managed Companies Award” Once Again
Eckert & Ziegler SE (ISIN DE0005659700) has won the “Best Managed Companies Award” for the third time in a row. With this honor, Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federati...
more ...Events Buch Berlin
27.08.2026, 10:00
CRISPR/Cas: Grundlagen und praktische Anwendung (Verschoben vom 4. Juni auf 27. August)
Der Crashkurs für Einsteiger*innen vermittelt die Grundlagen der CRISPR/Cas Technologie. Die Teilnehmer*innen sollen in die Lage versetzt werden, CRISPR/Cas Experimente selbständig zu planen und durch...
more ...22.09.2026, 09:00
GMP Biotech Summer School
Knowing and applying the Good Manufacturing Practice (GMP) regulations is one of the key elements in the manufacture of medicinal products for clinical trials and on an industrial level.
more ...09.11.2026, 09:00
Fachkraft für Molekularbiologie
Elftägiges Intensivseminar der Berlin BioScience Academy. Es rmittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschu...
more ...
